And our results showed that ZBTB7A was involved in the progression of NAFLD, and ZBTB7A was closely correlated with the serum TNFα and IL-6 levels (Figures 3(f) and 3(g)). Here, ZBTB7A is linked to metabolic dysfunction-associated steatotic liver disease.